|
|
News & Events
News
|
22-Oct-2008
The Biotechnology Division of the OECD organized an experts workshop on “Knowledge Markets in the Life Sciences” in Washington, DC on October 16-17, 2008. Its purpose was to explore whether Knowledge Markets could be more broadly used and to identify what governments may need to do to help make such new markets become a reality. This workshop is the first policy meeting to consider what new exchange mechanisms improve access to and use of the vast amounts of data, knowledge and information created in the biomedical sciences.
|
|
22-Oct-2008
At a workshop organized by the OECD Biotechnology Division in October in the United Kingdom, experts discussed how to improve the development and use of biomarkers in health care. Topics included: data and knowledge sharing for biomarker research; the creation of an evidence base and the clinical evaluation of biomarkers; the regulatory and policy framework for safe and efficient development of biomarkers; and business models for biomarker discovery, development and commercialization.
|
|
12-Sep-2008
This document provides a snapshot of the latest available internationally comparable data on patents. The indicators presented are specifically designed to reflect recent trends in inventive activities across a wide range of OECD member and non-member countries.
|
|
30-Jun-2008
The IFP has released a number of documents prepared within the context of “The Bioeconomy to 2030” project. These documents include scenarios as well as analytical reports and cover business models, ethics, intellectual property, and regulation. The reports are inputs to the project’s final report which is being prepared by the OECD and will be available in early 2009. For more information, please contact David Sawaya at david.sawaya@oecd.org.
|
|
06-Jun-2008
This database presents patent data linked to regions according to the addresses of the applicants and inventors. The data have been regionalised at a very detailed level so that over 2000 regions are covered across OECD countries. REGPAT allows patent data to be used in connection with other regional data, thus providing researchers with the means to develop a rich set of new indicators and undertake a broad range of analyses to address the regional dimension of innovation.
|
|
28-Feb-2008
This report, which was prepared by Matthew Herder and E. Richard Gold of The Innovation Partnership and covers intellectual property issues in health and industrial biotechnology, is an example of work being undertaken within the Bioeconomy to 2030 project. For more information, please contact either Mr. Anthony Arundel at Anthony.Arundel@oecd.org or Mr. David Sawaya at David.Sawaya@oecd.org.
|
|
12-Oct-2007
This new STI working paper aims at designing simple but robust methods that would enable to forecast the present (or recent past) in order to improve the timeliness of patent indicators.
|
|
04-Jun-2007
Governments should work more closely with companies and strengthen enforcement to fight the rising global trade in counterfeit and pirated goods, according to a new OECD report.
|
|
05-Sep-2006
This text was prepared by the Task Force for the Safety of Novel Foods and Feeds to provide an introduction to the consensus documents of the OECD’s Task Force. It explains, amongst other things, why the Task Force decided to prepare consensus documents as part of its programme of work. It describes their purpose and their use as a practical contribution to the risk/safety assessment of foods and feeds derived from transgenic organisms. It also explains the process by which consensus documents are drafted and brought to final publication.
|
|
30-Aug-2006
These OECD Biosafety Consensus Documents identify elements of scientific information used in the environmental safety and risk assessment of transgenic organisms which are common to OECD member countries. This is intended to encourage information sharing and prevent duplication of effort among countries. This book offers ready access to those consensus documents which have been published thus far. As such, it should be of value to applicants for commercial uses of transgenic crops, regulators in national authorities as well as the wider scientific community.
|
Top of page
|
|
A free and easy way to receive the latest news releases and media alerts